Deerfield Management, a healthcare hedge fund, has invested $100 million in a new research and development partnership with Cambridge, Mass.-based Harvard University, according to The Boston Globe.
Pharmacy
Purdue Pharma's CEO said a bankruptcy filing is on the table as lawsuits alleging the drugmaker fueled the nation's opioid crisis pile up, according to The Washington Post.
Entry of generic drugs into the market should cause prices to drop. However, the generic industry has recently taken a page from the brand-name industry, engaging in price gouging and making it increasingly difficult to obtain critical medications, Marc Harrison,…
As costs continue to mount from opioid litigation, Insys Therapeutics faces the risk of going out of business, according to Bloomberg.
Several drugmakers and pharmacy chains are hard at work responding to the hundreds of lawsuits accusing them of fueling the deadly opioid epidemic in the U.S. While billions of dollars are at stake for these companies if they are found…
Advertisement
Specialty drugmaker Sonoma Pharmaceuticals will reduce its workforce in an effort to slow "cash burn."
In 2018, Abbvie's rheumatoid arthritis drug Humira once again topped the list of best-selling drugs, according to a new analysis published in Nature.
The FDA approved a new generic of valsartan Feb. 12 to help relieve the shortage of the critical blood pressure drug that resulted from a string of recent recalls.
Facing pressure from investors, Rite Aid will replace three of its top executives and shed 400 corporate jobs.
The Senate Finance Committee has invited leaders from five major pharmacy benefit managers to testify at an April 3 hearing about high prescription drug costs in the U.S., according to CNBC.